+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical evaluation of an anticholinergic in the irritable colon syndrome; a double blind study of tricyclamol



Clinical evaluation of an anticholinergic in the irritable colon syndrome; a double blind study of tricyclamol



American Journal of Gastroenterology 31(1): 47-52




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 048544703

Download citation: RISBibTeXText

PMID: 13606113


Related references

Mebeverine in patients with the irritable colon syndrome: double blind study. New Zealand Medical Journal 77(491): 232-235, 1973

Trimipramin (Surmontil) and placebo in irritable colon syndrome. A double-blind study. Tidsskrift for den Norske Laegeforening 103(11): 903-905, 1983

Clinical assessment double blind drug trials and computer analysis of patients with moderately severe irritable colon syndrome. Gastroenterology 64(4): A-144-2-829, 1973

Irritable colon syndrome: therapeutic activity of otilonium bromide alone or in combination with benzodiazepine. Controlled double-blind study. La Clinica Terapeutica 109(6): 525-531, 1984

A balloonkymographic study of the effects of tricyclamol on colonic motility in irritable colon. American Journal of Gastroenterology 31(1): 42-46, 1959

Clinical and functional evaluation of octilonium bromide in the treatment of irritable bowel syndrome a double blind controlled trial. Clinical Trials Journal 20(2): 77-88, 1983

Evaluation of tricyclic compound (trimipramine) vis-a-vis placebo in irritable bowel syndrome. (Double blind randomised study). Journal of the Association of Physicians of India 31(4): 201-203, 1983

The therapeutic control of the irritable colon. Clinical investigation with a double-blind technic. Praxis 54(51): 1559-1562, 1965

Herbal medicine in the treatment of irritable bowel syndrome A double blind placebo controlled clinical study of Appital. Scandinavian Journal of Gastroenterology 31(Suppl. 217): 31, 1996

Management of irritable colon double blind evaluation of mepenzolate bromide combined with meprobamate. Clinical Medicine: 32-41, 1969

Drug therapy of the unstable bowel (irritable colon) a 15-month double blind clinical study in 75 cases of response to a prolonged-acting belladonna alkaloid-phenobarbital mixture or placebo. Journal of Chronic Diseases 9(4): 394-404, 1959

Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study. Alimentary Pharmacology and Therapeutics 34(8): 868-877, 2012

Efficacy of fenoverine and trimebutine in the management of irritable bowel syndrome: multicenter randomized double-blind non-inferiority clinical study. Korean Journal of Gastroenterology 62(5): 278-287, 2014

Randomised clinical trial the safety and efficacy of AST-12 in non-constipating irritable bowel syndrome – a double-blind, placebo-controlled study. 2011

Treatment of irritable colon with bran. A double-blind controlled study. Ugeskrift for Laeger 138(49): 3116-3118, 1976